SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
S-3

Simplified registration form

Registration Statements
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
CORRESP

CORRESP

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
EFFECT

EFFECT

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe